Immuron (IMRN) Other Working Capital Changes (2020 - 2023)
Immuron (IMRN) posted quarterly Other Working Capital Changes of -$1.7 million for Q2 2023, up 23.07% year-over-year from -$1.4 million in Q2 2022, and up 23.07% quarter-over-quarter from -$2.3 million in Q2 2022.
Immuron (IMRN) Other Working Capital Changes (2020 - 2023) Analysis & Trends
Immuron's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$1.7 million for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Immuron | 6.64 Mn | 6.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.73 Mn |
| Jun 30, 2023 | -1.73 Mn |
| Jun 30, 2023 | -1.73 Mn |
| Jun 30, 2022 | -2.25 Mn |
| Jun 30, 2022 | -2.25 Mn |
| Jun 30, 2022 | -2.25 Mn |
| Jun 30, 2021 | -3.14 Mn |
| Jun 30, 2021 | -3.14 Mn |
| Jun 30, 2021 | -3.14 Mn |
| Jun 30, 2020 | -2.06 Mn |
| Jun 30, 2020 | -2.06 Mn |
| Jun 30, 2020 | -2.06 Mn |